RT Journal Article
SR Electronic
T1 Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
JF BMJ Open Respiratory Research
JO BMJ Open Resp Res
FD British Thoracic Society
SP e000571
DO 10.1136/bmjresp-2020-000571
VO 7
IS 1
A1 Sara Panigone
A1 Federica Sandri
A1 Rossella Ferri
A1 Andrea Volpato
A1 Elena Nudo
A1 Gabriele Nicolini
YR 2020
UL http://bmjopenrespres.bmj.com/content/7/1/e000571.abstract
AB Patients with asthma and Chronic Obstructive Respiratory Disease (COPD) rely on three main device classes for inhalation therapy: metered-dose inhalers (MDIs), dry powder inhalers (DPIs) and soft-mist inhalers (SMIs). The carbon footprint (CF) of these inhalers differs with MDIs having a higher impact than DPIs and SMIs due to the propellant in MDIs. However, the certified CF of specific MDI products may differ significantly. MDIs still represent an essential option for many patients. Consequently, novel approaches shall be considered to balance environmental goals with patient health and well-being while maintaining a diverse range of choices for patients and physicians.